Soleno Therapeutics Management

How experienced are the management team and are they aligned to shareholders interests?


Average management tenure


Anish Bhatnagar (52 yo)





Dr. Anish Bhatnagar, M.D. has been Chief Executive Officer and Director of Soleno Therapeutics, Inc. since February 6, 2014 and serves as its President and Chief Operating Officer. Dr. Bhatnagar served as...

CEO Compensation Analysis

Anish Bhatnagar's Compensation vs Soleno Therapeutics Earnings
How has Anish Bhatnagar's remuneration changed compared to Soleno Therapeutics's earnings?
DateTotal Comp.SalaryCompany Earnings
Jun 30 2022n/an/a


Mar 31 2022n/an/a


Dec 31 2021US$4mUS$538k


Sep 30 2021n/an/a


Jun 30 2021n/an/a


Mar 31 2021n/an/a


Dec 31 2020US$3mUS$504k


Sep 30 2020n/an/a


Jun 30 2020n/an/a


Mar 31 2020n/an/a


Dec 31 2019US$822kUS$470k


Sep 30 2019n/an/a


Jun 30 2019n/an/a


Mar 31 2019n/an/a


Dec 31 2018US$952kUS$460k


Sep 30 2018n/an/a


Jun 30 2018n/an/a


Mar 31 2018n/an/a


Dec 31 2017US$1mUS$446k


Sep 30 2017n/an/a


Jun 30 2017n/an/a


Mar 31 2017n/an/a


Dec 31 2016US$959kUS$460k


Sep 30 2016n/an/a


Jun 30 2016n/an/a


Mar 31 2016n/an/a


Dec 31 2015US$1mUS$435k


Compensation vs Market: Anish's total compensation ($USD4.38M) is above average for companies of similar size in the US market ($USD772.00K).

Compensation vs Earnings: Anish's compensation has increased whilst the company is unprofitable.

Leadership Team

Experienced Management: SLNO's management team is seasoned and experienced (5.7 years average tenure).

Board Members

Experienced Board: SLNO's board of directors are considered experienced (6 years average tenure).